|
Predictive PK/PD models for hematological toxicities to inform MTD determination and regimen selection for ADCs. |
| |
|
Employment - Pfizer; Takeda |
Stock and Other Ownership Interests - Pfizer |
Travel, Accommodations, Expenses - Pfizer |
| |
|
|
Stock and Other Ownership Interests - Pfizer |
Travel, Accommodations, Expenses - Pfizer |
| |
|
|
Stock and Other Ownership Interests - Pfizer |
Travel, Accommodations, Expenses - Pfizer |
| |
|
No Relationships to Disclose |